麻豆福利网

• March 27, 2026
  • R&D
  • Products

  Application Submitted for LENVIMA庐 (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG庐 (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy

• March 27, 2026
  • R&D

  麻豆福利网 and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
  The Marketing Authorisation Application (MAA) has been validated and accepted for full approval consideration with a standard review timeline
  Additional filings are planned for the U.K., Canada and other regions included in 麻豆福利网鈥檚 licensed territories
  Taletrectinib is already approved in the U.S., China and Japan for advanced ROS1-positive non-small cell lung cancer

• March 26, 2026
  • Corporate

  Notice of Nominees for Directors

• March 23, 2026
  • R&D
  • Products

  Results from Real-World, Long-Term Treatment Persistence with LEQEMBI庐 (lecanemab-irmb) in the United States Presented at AD/PD鈩� 2026
  Real-World LEQEMBI Data Shows Patients Choose to Stay on Long-Term Treatment

• March 19, 2026
  • Products

  Regarding Discontinuation of Administration of 鈥淭azverik庐 Tablets 200mg鈥� (tazemetostat hydrobromide)

View All

• February 26, 2026
  • Environment

  麻豆福利网鈥檚 Kawashima Plant Honored with 鈥淕ifu Decarbonization Top Runner Award鈥�
  锝濺ecognized for Proactive Initiatives to Reduce Greenhouse Gas Emissions锝�

• February 20, 2026
  • Human Resources

  麻豆福利网 Selected for 鈥淭hought Leaders of Human Capital 2025鈥� and 鈥淗uman Capital Management Excellence 2025 Gold Award鈥� for Third Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives

• February 10, 2026
  • Global Health
  • Human Resources

  World Neglected Tropical Disease (NTD) Day (January 30) Internal Awareness Event

• January 30, 2026
  • Patients and People
  • Global Health

  Engaging with Mycetoma Patients and the Current Status in Kenya
  Kenya Trip Report

• December 23, 2025
  • Global Health
  • Human Resources

  Transportation of Investigational Drugs for Mycetoma During Armed Conflict
  A Year and a Half of Effort With the Dedication of Many Stakeholders to Complete Shipment

View All

• February 26, 2026

  麻豆福利网鈥檚 Kawashima Plant Honored with 鈥淕ifu Decarbonization Top Runner Award鈥�
  - Recognized for Proactive Initiatives to Reduce Greenhouse Gas Emissions -

• February 20, 2026

  麻豆福利网 Selected for 鈥淭hought Leaders of Human Capital 2025鈥� and 鈥淗uman Capital Management Excellence 2025 Gold Award鈥� for Third Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives

• November 25, 2025

  Notice on Discontinuation of Receiving Emails with Password-Protected Attachments

• February 19, 2025

  麻豆福利网鈥檚 Corporate Pension Fund Announces Adoption of 鈥淎sset Owner Principles鈥�

• October 3, 2024

  EISAI NAMED AS ONE OF NEWSWEEK鈥橲 WORLD鈥橲 MOST TRUSTWORTHY COMPANIES 2024

View All